DCM
CPXX

Dupont Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Dupont Capital Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,700
Closed -$504K – 757
2016
Q2 		$504K Buy
+16,700
New +$339K 0.01% 579

Dupont Capital Management's CPXX Position: Q3 2016 in Review

Dupont Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 16,700 shares — an estimated $504K sold.

Dupont Capital Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $504K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Dupont Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Dupont Capital Management sold 16,700 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $504K.
  • Dupont Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Dupont Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $504K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Dupont Capital Management's 13F filing for Q3 2016, filed 1 Nov 2016.